IBM Think 2026 Focuses on AI and Quantum Computing

Overview

Following its attendance at IBM Think 2026, UBS issued a commentary. The conference’s central themes were AI and hybrid cloud, with quantum computing increasingly positioned as a key differentiator. IBM demonstrated advancements in AI agents, the capabilities of the z17 system, and recent progress in quantum computing, while emphasizing how products like Sovereign Core address customer requirements for regulatory compliance and autonomous control. UBS reaffirmed its neutral rating and $236 price target for IBM, concluding that the current stock price largely reflects the company’s fundamental progress. It forecasts roughly a 3% upside over 12 months, with a total return of 6.0%, slightly below the market average.

Core views

UBS found IBM’s messaging at Think 2026 broadly consistent, centered on its hardware and software suite for helping clients navigate multi-cloud environments, with particular emphasis on developments in its AI ecosystem. IBM highlighted its progress in AI agent orchestration and the capabilities of the z17 system, as well as the role of Sovereign Core and Bob in addressing customer needs for hybrid cloud and AI deployments. Regarding quantum computing, IBM increasingly views it as a critical competitive differentiator. The CEO noted that the industry is expected to achieve quantum supremacy in 2026, warning that companies ignoring this paradigm shift will fall behind. IBM now offers access to over 80 quantum computers via the cloud, serving more than 300 customers worldwide; since 2023, it has deployed over 30 systems equipped with 100+ qubits, and the Qiskit SDK has supported more than 7,800 quantum-related projects. Additionally, cumulative quantum contract value since inception has surpassed $1 billion, with projections suggesting quantum hardware providers could capture roughly $200 billion in industry value. Despite these positive developments, UBS believes the current stock price fully reflects fundamentals and maintains a neutral stance. The $236 price target is derived from an estimated 18x CY27 EPS ($13.26), a multiple that implies organic growth of 3–4%, reflecting a discount compared to peers whose revenue grows in the mid-single digits.

Analysis framework

UBS employs an event-driven analytical framework: first, observations from the conference confirm the company’s strategic priorities and product roadmap, treating IBM’s demonstrations in AI and quantum as validation of business progress; second, industry trends are mapped onto the financial model and valuation framework. For valuation, the firm uses the P/E method, multiplying a 12-month target P/E ratio by its forecasted CY27 diluted EPS to derive the price target. This multiple implicitly embeds growth expectations (3–4%) and is compared against peers (mid-single-digit growth) to assess pricing reasonableness. Finally, the investment rating is determined by comparing the forecasted stock return (FSR, including expected price appreciation plus dividend yield) with the market return assumption (MRA, local interest rate plus a 5% equity risk premium): FSR exceeding MRA by 6% or more warrants a buy rating, below 6% a sell, and between constitutes neutrality.

Methodology notes

• Valuation MethodPE/PEG valuation

  Price target derived by multiplying P/E ratio by future-year EPS

  UBS sets IBM’s price target at approximately 18 times its projected CY27 (2027) EPS. This means the firm forecasts the company’s earnings for the coming year and applies a specific P/E multiple to back-calculate a fair current stock price; the chosen multiple reflects expectations for future growth.

• Valuation Method

  Rating framework based on comparison between Forecasted Stock Return (FSR) and Market Return Assumption (MRA)

  FSR represents the expected price appreciation over the next 12 months plus the dividend yield; MRA is the one-year local interest rate plus 5% (as an equity risk premium proxy). If FSR exceeds MRA by 6% or more, the recommendation is buy; below 6%, sell; in between, neutral. In this case, IBM’s projected total return is 6.0%, slightly below the MRA of 8.9%, hence the neutral rating.

• Industry/Industrial Analysis FrameworkPenetration S-curve

  Inflection point of quantum advantage and early stages of penetration

  The report notes that the CEO anticipates the industry achieving quantum supremacy in 2026—a pivotal transition from R&D to commercial deployment. The firm assesses the maturity of this emerging technology by tracking the number of deployed systems, the size of the customer base, and related contract values, placing it in the early climb phase of an S-shaped penetration curve.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• International Business Machines Corporation (IBM.N)

  Subject of this report, benefiting from long-term growth in AI, hybrid cloud, and quantum computing

  Strengths

  Leadership position in quantum computing, with a large installed base of quantum systems and a broad customer network; its product portfolio effectively supports customers’ regulatory compliance and autonomous control needs in hybrid cloud environments

  Weaknesses

  Organic revenue growth is projected at only 3–4%, lagging behind peers whose growth rates are in the mid-single digits

  Comparison

  The valuation multiple (roughly 18x PE) discounts IBM relative to larger competitors with faster revenue expansion

  Risks

  Macroeconomic pressures leading to weaker IT spending; slowdown in services weighing on revenue; intensifying competition squeezing margins; short-term challenges associated with the transition to mainframe products

Key data

• Price TargetUS$236.0012-month target price, unchanged
• Current Share PriceUS$229.05As of May 5, 2026
• Projected Price Appreciation3.0%Expected 12-month upside
• Projected Dividend Yield3.0%Expected dividend payout ratio
• Projected Total Stock Return6.0%Sum of expected price gain and dividend yield
• Target P/E RatioApproximately 18xBased on projected CY27 EPS
• Projected CY27 Diluted EPSUS$13.26UBS’s forecast for 2027 diluted EPS
• Cumulative Quantum Contract ValueOver $1 billionTotal since inception through Q4 2024
• Potential Quantum Market SizeApproximately $200 billionEstimated share of industry value extractable by quantum hardware providers

Impact & implications

The report concludes that IBM’s sustained investment in quantum computing is gradually establishing a differentiated competitive edge and could unlock a market worth tens of billions of dollars over the medium to long term. Meanwhile, products like Sovereign Core for AI and hybrid cloud effectively address customer pain points related to compliance and control in multi-cloud environments. However, because the commercialization of these cutting-edge businesses remains some time away and the current stock valuation already fairly reflects underlying progress, the report sees no clear near-term catalyst for a significant revaluation and thus maintains a neutral stance.

Risks

• Macroeconomic concerns dampening IT spending, particularly in high-exposure sectors like finance and the public sector
• A slowdown in services resulting in revenue shortfalls
• Intensified competition putting pressure on profit margins
• Short-term challenges arising from the transition to mainframe products
• Stronger global GDP and increased market share driving higher-than-expected consulting and software spending—upside risk that could prompt a valuation revision

What to watch

• Whether the industry achieves the quantum supremacy inflection point in 2026 as expected
• Subsequent growth in quantum-related contract value and progress toward commercialization